ACTA2 was highly expressed in grade 4 gliomas compared to grade 3 gliomas in clinical malignant glioma specimens, and multiple distant brain lesions were more common in the ACTA2 high expression group. The gene discussed is ACTA2; the disease is central nervous system cancer.